AAAAAA

   
Results: 1-7 |
Results: 7
The Food and Drug Administration approval of endovascular grafts for abdominal aortic aneurysm: An 18-month retrospective
Authors: Sapirstein, W Chandeysson, P Wentz, C
Citation: W. Sapirstein et al., The Food and Drug Administration approval of endovascular grafts for abdominal aortic aneurysm: An 18-month retrospective, J VASC SURG, 34(1), 2001, pp. 180-183
FDA approval of coronary-artery brachytherapy
Authors: Sapirstein, W Zuckerman, B Dillard, J
Citation: W. Sapirstein et al., FDA approval of coronary-artery brachytherapy, N ENG J MED, 344(4), 2001, pp. 297-299
Intracoronary radiotherapy for restenosis - Reply
Authors: Sapirstein, W Zuckerman, B Dillard, J
Citation: W. Sapirstein et al., Intracoronary radiotherapy for restenosis - Reply, N ENG J MED, 344(23), 2001, pp. 1796-1796
Database: Relevant or not
Authors: Pae, WE Kormos, RL Greene, PS Sapirstein, W
Citation: We. Pae et al., Database: Relevant or not, ANN THORAC, 71(3), 2001, pp. S204-S209
Designing trials for testing prosthetic cardiac valves: A Food and Drug Administration perspective
Authors: Sapirstein, W
Citation: W. Sapirstein, Designing trials for testing prosthetic cardiac valves: A Food and Drug Administration perspective, AM HEART J, 141(5), 2001, pp. 861-863
The conduct of clinical trials: A food and drug agency perspective
Authors: Sapirstein, W
Citation: W. Sapirstein, The conduct of clinical trials: A food and drug agency perspective, ASAIO J, 46(1), 2000, pp. 29-30
Functional assessment of skeletal muscle ventricles after pumping for up to four years in circulation - Discussion
Authors: Huddleston, CB",Thomas,"Mannon, JD Sapirstein, W
Citation: Jd. Huddleston, Cb",thomas,"mannon et W. Sapirstein, Functional assessment of skeletal muscle ventricles after pumping for up to four years in circulation - Discussion, ANN THORAC, 70(4), 2000, pp. 1290-1290
Risultati: 1-7 |